Suppression of carbon tetrachloride-induced liver fibrosis by transplantation of a clonal mesenchymal stem cell line derived from rat bone marrow

Marhaen Hardjo, Masahiro Miyazaki, Masakiyo Sakaguchi, Takuro Masaka, Sukaeni Ibrahim, Ken Kataoka, Nam Ho Huh

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Transplantation of hepatocytes or bone marrow-derived cells has been shown to ameliorate liver fibrosis in animal models, but no direct comparison of relative efficiency has been made. The aim of this study was to compare the efficiency of a bone marrow-derived clonal mesenchymal stem cell line established by us (rBM25/S3) with that of its adipogenic or hepatogenic differentiation derivative for suppression of rat liver fibrosis. After induction of differentiation of rBM25/S3 cells into adipogenic or hepatogenic cells in culture, we intrasplenically transplanted the three types of cells into rats (3 × 107 cells/rat) before and 4 weeks after initiation of carbon tetrachloride treatment (1 ml/kg body weight twice a week for 8 weeks) to induce liver fibrosis. Undifferentiated rBM25/S3 cells were the most effective for suppression of liver fibrosis, followed by the adipogenic cells and hepatogenic cells. Expression levels of MMP-2 and MMP-9 were also highest in undifferentiated rBM25/S3 cells. These results indicate that bone marrow-derived clonal mesenchymal stem cell lines are useful for further mechanistic studies on cell-mediated suppression of liver fibrosis and that such cell lines will provide information on an appropriate cell source for transplantation therapy for cirrhosis.

Original languageEnglish
Pages (from-to)89-99
Number of pages11
JournalCell Transplantation
Volume18
Issue number1
DOIs
Publication statusPublished - 2009

Fingerprint

Carbon tetrachloride
Carbon Tetrachloride
Stem cells
Mesenchymal Stromal Cells
Liver Cirrhosis
Liver
Liver Transplantation
Rats
Bone
Bone Marrow
Cell Line
Matrix Metalloproteinases
Animals
Cells
Cell Transplantation
Derivatives
Bone Marrow Cells
Hepatocytes
Fibrosis
Animal Models

Keywords

  • Liver fibrosis
  • Mesenchymal stem cells

ASJC Scopus subject areas

  • Cell Biology
  • Transplantation
  • Biomedical Engineering

Cite this

Suppression of carbon tetrachloride-induced liver fibrosis by transplantation of a clonal mesenchymal stem cell line derived from rat bone marrow. / Hardjo, Marhaen; Miyazaki, Masahiro; Sakaguchi, Masakiyo; Masaka, Takuro; Ibrahim, Sukaeni; Kataoka, Ken; Huh, Nam Ho.

In: Cell Transplantation, Vol. 18, No. 1, 2009, p. 89-99.

Research output: Contribution to journalArticle

Hardjo, Marhaen ; Miyazaki, Masahiro ; Sakaguchi, Masakiyo ; Masaka, Takuro ; Ibrahim, Sukaeni ; Kataoka, Ken ; Huh, Nam Ho. / Suppression of carbon tetrachloride-induced liver fibrosis by transplantation of a clonal mesenchymal stem cell line derived from rat bone marrow. In: Cell Transplantation. 2009 ; Vol. 18, No. 1. pp. 89-99.
@article{8a8dd0a0ef2444a2a4445c9277a31418,
title = "Suppression of carbon tetrachloride-induced liver fibrosis by transplantation of a clonal mesenchymal stem cell line derived from rat bone marrow",
abstract = "Transplantation of hepatocytes or bone marrow-derived cells has been shown to ameliorate liver fibrosis in animal models, but no direct comparison of relative efficiency has been made. The aim of this study was to compare the efficiency of a bone marrow-derived clonal mesenchymal stem cell line established by us (rBM25/S3) with that of its adipogenic or hepatogenic differentiation derivative for suppression of rat liver fibrosis. After induction of differentiation of rBM25/S3 cells into adipogenic or hepatogenic cells in culture, we intrasplenically transplanted the three types of cells into rats (3 × 107 cells/rat) before and 4 weeks after initiation of carbon tetrachloride treatment (1 ml/kg body weight twice a week for 8 weeks) to induce liver fibrosis. Undifferentiated rBM25/S3 cells were the most effective for suppression of liver fibrosis, followed by the adipogenic cells and hepatogenic cells. Expression levels of MMP-2 and MMP-9 were also highest in undifferentiated rBM25/S3 cells. These results indicate that bone marrow-derived clonal mesenchymal stem cell lines are useful for further mechanistic studies on cell-mediated suppression of liver fibrosis and that such cell lines will provide information on an appropriate cell source for transplantation therapy for cirrhosis.",
keywords = "Liver fibrosis, Mesenchymal stem cells",
author = "Marhaen Hardjo and Masahiro Miyazaki and Masakiyo Sakaguchi and Takuro Masaka and Sukaeni Ibrahim and Ken Kataoka and Huh, {Nam Ho}",
year = "2009",
doi = "10.3727/096368909788237140",
language = "English",
volume = "18",
pages = "89--99",
journal = "Cell Transplantation",
issn = "0963-6897",
publisher = "Cognizant Communication Corporation",
number = "1",

}

TY - JOUR

T1 - Suppression of carbon tetrachloride-induced liver fibrosis by transplantation of a clonal mesenchymal stem cell line derived from rat bone marrow

AU - Hardjo, Marhaen

AU - Miyazaki, Masahiro

AU - Sakaguchi, Masakiyo

AU - Masaka, Takuro

AU - Ibrahim, Sukaeni

AU - Kataoka, Ken

AU - Huh, Nam Ho

PY - 2009

Y1 - 2009

N2 - Transplantation of hepatocytes or bone marrow-derived cells has been shown to ameliorate liver fibrosis in animal models, but no direct comparison of relative efficiency has been made. The aim of this study was to compare the efficiency of a bone marrow-derived clonal mesenchymal stem cell line established by us (rBM25/S3) with that of its adipogenic or hepatogenic differentiation derivative for suppression of rat liver fibrosis. After induction of differentiation of rBM25/S3 cells into adipogenic or hepatogenic cells in culture, we intrasplenically transplanted the three types of cells into rats (3 × 107 cells/rat) before and 4 weeks after initiation of carbon tetrachloride treatment (1 ml/kg body weight twice a week for 8 weeks) to induce liver fibrosis. Undifferentiated rBM25/S3 cells were the most effective for suppression of liver fibrosis, followed by the adipogenic cells and hepatogenic cells. Expression levels of MMP-2 and MMP-9 were also highest in undifferentiated rBM25/S3 cells. These results indicate that bone marrow-derived clonal mesenchymal stem cell lines are useful for further mechanistic studies on cell-mediated suppression of liver fibrosis and that such cell lines will provide information on an appropriate cell source for transplantation therapy for cirrhosis.

AB - Transplantation of hepatocytes or bone marrow-derived cells has been shown to ameliorate liver fibrosis in animal models, but no direct comparison of relative efficiency has been made. The aim of this study was to compare the efficiency of a bone marrow-derived clonal mesenchymal stem cell line established by us (rBM25/S3) with that of its adipogenic or hepatogenic differentiation derivative for suppression of rat liver fibrosis. After induction of differentiation of rBM25/S3 cells into adipogenic or hepatogenic cells in culture, we intrasplenically transplanted the three types of cells into rats (3 × 107 cells/rat) before and 4 weeks after initiation of carbon tetrachloride treatment (1 ml/kg body weight twice a week for 8 weeks) to induce liver fibrosis. Undifferentiated rBM25/S3 cells were the most effective for suppression of liver fibrosis, followed by the adipogenic cells and hepatogenic cells. Expression levels of MMP-2 and MMP-9 were also highest in undifferentiated rBM25/S3 cells. These results indicate that bone marrow-derived clonal mesenchymal stem cell lines are useful for further mechanistic studies on cell-mediated suppression of liver fibrosis and that such cell lines will provide information on an appropriate cell source for transplantation therapy for cirrhosis.

KW - Liver fibrosis

KW - Mesenchymal stem cells

UR - http://www.scopus.com/inward/record.url?scp=66849113865&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66849113865&partnerID=8YFLogxK

U2 - 10.3727/096368909788237140

DO - 10.3727/096368909788237140

M3 - Article

VL - 18

SP - 89

EP - 99

JO - Cell Transplantation

JF - Cell Transplantation

SN - 0963-6897

IS - 1

ER -